INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 166 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,226,000 | -6.6% | 53,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,312,000 | -46.4% | 53,100 | -10.1% | 0.00% | -50.0% |
| Q3 2020 | $2,450,000 | -10.9% | 59,093 | +3.0% | 0.00% | -33.3% |
| Q2 2020 | $2,750,000 | -22.1% | 57,393 | +2.4% | 0.00% | -25.0% |
| Q1 2020 | $3,528,000 | -66.1% | 56,029 | -33.3% | 0.00% | -55.6% |
| Q4 2019 | $10,405,000 | +240.7% | 83,965 | +82.4% | 0.01% | +200.0% |
| Q3 2019 | $3,054,000 | +19.6% | 46,029 | +43.4% | 0.00% | 0.0% |
| Q2 2019 | $2,554,000 | -26.6% | 32,094 | +3.2% | 0.00% | -25.0% |
| Q1 2019 | $3,478,000 | +15.5% | 31,088 | +4.1% | 0.00% | 0.0% |
| Q4 2018 | $3,010,000 | -5.1% | 29,865 | +19.0% | 0.00% | 0.0% |
| Q3 2018 | $3,172,000 | +40.0% | 25,100 | -7.0% | 0.00% | +33.3% |
| Q2 2018 | $2,266,000 | +14.0% | 27,000 | -16.4% | 0.00% | 0.0% |
| Q1 2018 | $1,987,000 | +5.3% | 32,300 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,887,000 | +3.2% | 32,300 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $1,828,000 | -51.3% | 31,500 | +1.6% | 0.00% | -50.0% |
| Q2 2017 | $3,753,000 | +9.5% | 31,000 | +2.3% | 0.01% | 0.0% |
| Q1 2017 | $3,427,000 | -0.5% | 30,300 | -4.4% | 0.01% | 0.0% |
| Q4 2016 | $3,444,000 | -37.2% | 31,700 | -4.8% | 0.01% | -33.3% |
| Q3 2016 | $5,481,000 | +7.6% | 33,300 | -6.7% | 0.01% | +12.5% |
| Q2 2016 | $5,094,000 | +7.4% | 35,700 | -3.3% | 0.01% | 0.0% |
| Q1 2016 | $4,741,000 | +76.4% | 36,900 | +105.0% | 0.01% | +100.0% |
| Q4 2015 | $2,688,000 | -9.9% | 18,000 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $2,985,000 | -31.3% | 18,000 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $4,345,000 | +31.2% | 18,000 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $3,313,000 | 0.0% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $3,313,000 | -22.2% | 18,000 | 0.0% | 0.01% | -16.7% |
| Q3 2014 | $4,260,000 | -16.7% | 18,000 | -16.7% | 0.01% | -14.3% |
| Q2 2014 | $5,111,000 | -14.4% | 21,601 | +5.4% | 0.01% | -22.2% |
| Q1 2014 | $5,970,000 | +42542.9% | 20,500 | +10150.0% | 0.01% | – |
| Q3 2013 | $14,000 | +55.6% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $9,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |